FDA product code NIQ: Coronary Drug-Eluting Stent
NIQ is the FDA product code for coronary drug-eluting stent. It is a Class III device, reviewed by the Cardiovascular panel. Devices under NIQ reach the market by PMA; FDA lists no cleared 510(k)s for it. 16 PMA applications cite this product code. FDA has posted 6 recalls for NIQ devices.
Definition
Stent, coronary, drug-eluting -- a metal scaffold with a drug coating placed via a delivery catheter into the coronary artery or saphenous vein graft to maintain the lumen. The drug coating is intended to inhibit restenosis.
Classification
| Field | Value |
|---|---|
| Device name | Coronary Drug-Eluting Stent |
| Device class | Class III |
| Review panel | CV — Cardiovascular |
| Medical specialty | Unknown |
| Premarket route | PMA |
| Implant | Yes |
| Life-sustaining or supporting | Yes |
Recalls for NIQ devices
6 product recalls in 6 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2020-03-25.
| Year | Recalls |
|---|---|
| 2020 | 1 |
HCPCS codes with matching descriptors
Text match between the FDA device name and CMS descriptors, not an official crosswalk:
- C9602 — Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch
- C9600 — Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch
Frequently asked questions
What is FDA product code NIQ?
NIQ is the FDA product code for coronary drug-eluting stent. It is a Class III device, reviewed by the Cardiovascular panel.
What device class is NIQ?
Class III. Typical premarket route: PMA.
Have NIQ devices been recalled?
Yes: 6 product recalls across 6 recall events; the most recent began 2020-03-25.
Next steps
- Run an FDA pathway report with predicate devices for product code NIQ
- Run a recall and safety report across every NIQ manufacturer
- Watch product code NIQ for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times